How to Get Financial Help for Biologic RA Treatments


Beth W. Orenstein

Was this helpful? (0)
This content is selected and managed by the Healthgrades editorial staff and is brought to you by an advertising sponsor.

This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and objectivity. The content is not edited or otherwise influenced by the advertisers appearing on this page except with the possible suggestion of the broad topic area. For more information, read the HealthGrades advertising policy.

Know What Your Insurance Covers

Since biologics were introduced in 1998, they have helped many people with rheumatoid arthritis function better. Two out of three people treated with biologics, which must be injected or given intravenously (through an IV), do well on them.

However, biologics are quite costly. They can range from $12,000 to $30,000 a year. Biologics are pricey because they are costly to produce. Biologics are genetically engineered medications made from living organisms. The raw materials needed are expensive and the manufacturing process is more complicated than other types of drugs.

Many health insurance plans will cover at least some of the cost. You need to check with your insurance company to find out whether it has any special requirements. For example, your insurance company may reimburse you differently for drugs given by injection or IV.

Some insurance plans will require you to get prior authorization before you receive injectable or specialty medications and are reimbursed for them. Also, if you are thinking of switching insurance plans, check to see whether coverage of your biologics will change.

Reducing Costs: Help From Manufacturers

Manufacturers that make these powerful drugs have a variety of programs that help people pay for their RA biologics. If you don’t have insurance or have a limited income, you are likely to qualify for their assistance.

You can find more information about eligibility and how to apply for assistance at these manufacturers’ websites:

Abatacept (Orencia)

Bristol-Myers Squibb Patient Assistance Foundation

Adalimumab (Humira)

Abbott Patient Assistance Foundation

Anakinra (Kineret)

Kineret Patient Assistance Program

Certolizumab Pegol (Cimzia)

Cimzia Co-Pay Savings Card

Etanercept (Enbrel)

Amgen/Pfizer ENcourage Foundation

Infliximab (Remicade)

Johnson & Johnson Patient Assistance Program

Golimumab (Simponi)

SimponiOne Support

Tocilizumab (Actemra)

Actemra Co-Pay Card Program

Reducing Costs: Help From Nonprofits

A number of nonprofit programs are available to help people who can’t afford their medications:


P.O. Box 219

Gloucester, MA 01931

NeedyMeds is an information resource that helps people who cannot afford medication or healthcare costs find programs that can assist them. You don’t have to identify yourself and may be able to get help free of charge.

The Patient Advocate Foundation

421 Butler Farm Road

Hampton, VA 23666

Was this helpful? (0)
Medical Reviewers: William C. Lloyd III, MD, FACS Last Review Date: Apr 9, 2015

© 2016 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

View Sources

Medical References

  1. 2011 Injectable Medications and Specialty Pharmaceutical Drugs. BlueChoice Health Plan, South Carolina.
  2. Bristol-Myers Squibb Patient Assistance Foundation.
  3. Cimzia Co-Pay Savings Card.
  4. Abbott Patient Assistance Foundation.
  5. Johnson & Johnson Patient Assistance Program.
  6. NeedyMeds.
  7. The Patient Advocate Foundation.
  8. Inc.
  9. Biologic Treatments for Rheumatoid Arthritis. American College of Rheumatology.
  10. RxAssist.
  11. Amgen/Pfizer ENcourage Foundation.
  12. Kineret Patient Assistance Program.

You Might Also Like

Share via Email


8 Rheumatoid Arthritis Myths


Is Your Rheumatoid Arthritis in Remission?